PsychedelicNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW) to Present at Upcoming H.C. Wainwright Psychedelics Conference
Jun 2, 2021
Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW), a pharmaceutical company focused on developing compounds for diseases with unmet medical needs through accelerated regulatory pathways, has announced that it will be presenting at H.C. Wainwright & Co.’s Psychedelics in Psychiatry and Beyond conference. The virtual event will be held on June 17, 2021. At the elite conference, Tryp chair and CEO Greg McKee will present an overview of the business including the company’s pipeline, which features its psilocybin-for-neuropsychiatric disorders, or PFN(TM) (“PFN”), program for chronic pain and eating disorder indications. McKee’s prerecorded presentation will be available beginning 7 a.m. EDT on the day of the conference. In addition, Tryp announced the adoption of a new form of stock option plan designed to align with certain U.S. regulatory requirements pursuant to the U.S. Internal Revenue Code. As a result, some company directors and officers who were granted stock options under the prior plan have requested that those options be cancelled and re-issued under the new plan. Tryp has obtained approval from the Canadian Securities Exchange for the move.
To register for the event, visit https://ibn.fm/DkhtI
To view the full press release, visit https://ibn.fm/QrWpF
About Tryp Therapeutics Inc.
Tryp Therapeutics is a pharmaceutical company focused on developing compounds for the treatment of diseases with accelerated regulatory pathways. Tryp’s psilocybin-for-neuropsychiatric disorders, or PFN(TM) (“PFN”), program is focused on the development of synthetic psilocybin as a new class of drug for the treatment of certain neuropsychiatric-based disorders. Tryp’s lead PFN drug candidate is TRP-8802 for the treatment of fibromyalgia, a chronic pain syndrome estimated to affect more than five million people in the United States. The company is also preparing to initiate a phase 2a clinical study for eating disorders in partnership with the Dr. Jennifer Miller at the University of Florida. For more information about the company, please visit www.TrypTherapeutics.com.
NOTE TO INVESTORS: The latest news and updates relating to Tare available in the company’s newsroom at https://ibn.fm/TRYPF
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.PsychedelicNewsWire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
[email protected]
PsychedelicNewsWire is part of the InvestorBrandNetwork.
More News
‘Horrible’ injury leaves Gillingham star sweating on Bristol Rovers clash
Gillingham are close to welcoming back several injured players for Saturday’s visit of Bristol Rovers – but striker Ronan Hale remains a doubt.
Gillingham defender rewarded with international call-up
Gillingham defender Conor McManus has been called up for international duty.
Gillingham’s injury crisis has created a problem Ainsworth won’t mind
Gillingham’s youngsters are making such an impression that some of the club’s senior players could find it difficult to win their shirts back.
Football fixtures and results
Catch up with all the week’s football fixtures and results here.
Promotion-chasing Kent on the verge of victory
Kent are closing in on victory in their Rothesay County Championship clash with Lancashire at Canterbury.
More to come for Gillingham Fan Zone after successful opening
More than 750 supporters checked out Gillingham’s new Fan Zone on Saturday as the club looks to enhance the matchday experience at Priestfield.
Gillingham youngsters fall to four-goal Birmingham defeat
Gillingham were beaten at home by a ruthless Birmingham City Academy side on Tuesday night in the Premier League Under-21 Cup.
Wickets tumble - but Crawley hits unbeaten half-century
An incredible 17 wickets fell as it proved a day to forget for the batsmen during Kent’s County Championship match with Lancashire at Canterbury.
‘I’m not going to miss out’ – Ainsworth reveals Gillingham’s cup plan
Gillingham’s manager wants to use Tuesday night’s Premier League Under-21 Cup clash to give some of his returning senior players valuable game-time.
Gillingham’s Ronan Hale injury update after starring in Tranmere victory
Gillingham striker Ronan Hale created the opener on Saturday but went off injured after scoring the second.
FA Trophy third qualifying round draw
The draw has been made for the third qualifying round of the FA Trophy.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.